Use of NanoBiT and NanoBRET to characterise interleukin-23 receptor dimer formation in living cells.

Lay, Charles S; Kilpatrick, Laura E; Craggs, Peter D; Hill, Stephen J

Lay, Charles S; Kilpatrick, Laura E; Craggs, Peter D; Hill, Stephen J.

Afiliação

Lay CS; Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.
Kilpatrick LE; Centre of Membrane Proteins and Receptors, University of Birmingham and Nottingham, The Midlands, UK.
Craggs PD; Medicine Design, Medicinal Science and Technology, GlaxoSmithKline, Stevenage, UK.
Hill SJ; Centre of Membrane Proteins and Receptors, University of Birmingham and Nottingham, The Midlands, UK.

Br J Pharmacol ; 180(11): 1444-1459, 2023 06.

Article em En | MEDLINE | ID: mdl-36560872

Assuntos

Interleucina-23; Transdução de Sinais; Ligantes; Luciferases/química; Luciferases/metabolismo; Multimerização Proteica; Sobrevivência Celular

Palavras-chave

IL12Rß1; IL23R; Interleukin-23; NanoBRET; NanoBiT; STAT3; cytokine-receptor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Interleucina-23 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google